Real-time enrollment status for this bladder cancer clinical trial
Current Status
Suspended
Checked: April 17, 2026 at 10:53 PM UTC
| NCT Number | NCT03375307 |
| Recruiting Status | Suspended |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 17 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | April 13, 2026 (4 days ago) |
As of April 17, 2026: Clinical trial NCT03375307 is currently suspended participants. This clinical trial study for bladder cancer is not currently accepting new participants at 17 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03375307 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03375307 was last updated 4 days ago (April 13, 2026). HelloStudys verifies this status automatically.